In vitro and in silico study demonstrates potent EGFR binding and antibacterial activity of a novel zinc complex, indicating therapeutic antimicrobial and anticancer potential.
The present study successfully describes the synthesis and comprehensive characterization of a novel Zn(II) coordination complex derived from a heterocyclic amide-based ligand. Spectroscopic analyses, including FT-IR and NMR, confirmed the successful formation of the ligand and its coordination with the zinc ion through the expected donor atoms. The structural features indicate the formation of a stable coordination environment suitable for biological applications. Molecular docking studies against the EGFR tyrosine kinase receptor demonstrated a favorable binding mode with a binding affinity of −8.90 kcal/mol, supported by hydrogen bonding and hydrophobic interactions within the active site. Furthermore, the synthesized complex exhibited concentration-dependent antibacterial activity against both Gram-positive and Gram-negative bacterial strains, with greater efficacy toward Gram-positive bacteria. Collectively, these findings highlight the potential of the synthesized Zn(II) complex as a promising scaffold for further development of biologically active coordination compounds with possible antimicrobial and anticancer applications.
No takes yet. Share an insight, caveat, or question.
Wisam Taher Muslim (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: